Bradykinin B1 Receptor Antagonism and Renal Injury
Author Information
Author(s): Wang Pamella H. M., Campanholle Gabriela, Cenedeze Marcos A., Feitoza Carla Q., Gonçalves Giselle M., Landgraf Richardt G., Jancar Sonia, Pesquero João B., Pacheco-Silva Alvaro, Câmara Niels O. S.
Primary Institution: Universidade Federal de São Paulo, São Paulo, Brazil
Hypothesis
Can bradykinin B1 receptor antagonism reduce renal ischemia-reperfusion injury?
Conclusion
Bradykinin B1 receptor antagonism is beneficial in reducing renal ischemia-reperfusion injury.
Supporting Evidence
- Bradykinin B1 receptor antagonism decreased serum creatinine levels.
- B1R knockout mice showed protection against renal ischemia.
- Increased expression of anti-inflammatory molecules was observed with B1R antagonism.
Takeaway
Blocking a specific receptor can help protect the kidneys from damage when blood flow is cut off and then restored.
Methodology
Mice were subjected to renal ischemia and treated with bradykinin receptor antagonists before analysis of kidney function and inflammatory markers.
Potential Biases
Potential bias in the selection of animal models and treatments.
Limitations
The study was conducted on mice, which may not fully represent human responses.
Participant Demographics
Isogenic male C57BL/6 mice aged 8–12 weeks.
Statistical Information
P-Value
0.005
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website